Skip to main content
BIO PROTECH INC. logo

BIO PROTECH INC. — Investor Relations & Filings

Ticker · 199290 ISIN · KR7199290008 LEI · 988400TYKP3J6SZOGR02 KO Manufacturing
Open in API
Filings indexed 281 across all filing types
Latest filing 2026-04-16 Capital/Financing Update
Country KR South Korea
Listing KO 199290

About BIO PROTECH INC.

https://www.protechsite.com/

BIO PROTECH INC. is a manufacturer of medical equipment and disposable supplies. The company develops and produces a range of products for applications in surgery, cardiology, neurology, and pain management. Its portfolio includes electrosurgical devices such as smoke evacuators and surgical pencils, various electrocardiogram (ECG) electrodes, and transcutaneous electrical nerve stimulation (TENS) units. The company specializes in bio-medical sensors and related products developed using advanced skin technology for the global healthcare market.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a Korean ‘주요사항보고서’ detailing a decision and correction regarding the issuance of convertible bonds, including terms, maturity extensions, conversion ratios, early redemption schedules, and related financing specifics. This is clearly a regulatory announcement of a financing activity (bond issuance), rather than an annual or interim report, earnings release, or governance filing. Thus it best fits the “Capital/Financing Update” category.
2026-04-16 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a Korean "주요사항보고서" reporting and correcting the details of a convertible bond issuance decision, including maturity extensions, redemption terms, conversion schedules, and related financing information. This is a direct corporate financing update regarding debt issuance and capital structure changes rather than a full annual or interim report, management discussion, or dividend/meeting materials. It falls under our "Capital/Financing Update" category.
2026-04-16 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled “정기주주총회 결과” (Ordinary Shareholders’ Meeting Results) and presents detailed voting outcomes for each agenda item (percentages, approval status) at the annual general meeting. This matches Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-03-31 Korean
[기재정정]사업보고서 (2025.12)
Annual Report Classification · 1% confidence The document is a 'Correction Report' (정정신고) for an Annual Report (사업보고서) filed by BioProtech. It explicitly lists the corrections made to various sections of the previously submitted Annual Report, such as company history, management changes, financial statement notes, and shareholder status. Since it is a formal amendment to an existing Annual Report, it is classified as an Annual Report (10-K) under the provided schema. FY 2026
2026-03-30 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Audit Report' (감사보고서) for the company 'BioProTech' (주식회사 바이오프로테크) for the fiscal year ending December 31, 2025. It includes the independent auditor's report from Samil PricewaterhouseCoopers, the full set of financial statements (Statement of Financial Position, Comprehensive Income Statement, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This is a formal, full-year audited financial report, which fits the definition of an Audit Report (AR) or a component of an Annual Report. Given the specific structure and the presence of the auditor's opinion, 'AR' is the most accurate classification. FY 2025
2026-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is titled “감사보고서 제출” (Audit Report Submission) and provides detailed audit opinions, summary financial statements for the current and preceding years, auditor name, receipt date, accounting standards applied, and related audit disclosures. This aligns exactly with a standalone audit report submission rather than an annual report or an announcement of report availability. Therefore, it should be classified as an Audit Report / Information (AR). FY 2025
2026-03-23 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.